Masaru Furukawa

Dr. Masaru Furukawa

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
MFMasaru Furukawa
Masaru Furukawa
YIYasutaka Ishii
Yasutaka Ishii
YTYumiko Tatsukawa
Yumiko Tatsukawa
SNShinya Nakamura
Shinya Nakamura
JIJuri Ikemoto
Juri Ikemoto
SOShiro Oka
Shiro Oka
Background/Purpose: Differential diagnosis of isolated immunoglobin (Ig)G4-related sclerosing cholangitis (IgG4-SC) and cholangiocarcinoma is challenging. We aimed to clarify the role of endoscopic retrograde cholangiography (ERCP)-related procedures in the differential diagnosis of isolated IgG4-SC and perihilar cholangiocarcinoma (PHCC). Methods: Seven patients with hilar-type isolated IgG4-SC diagnosed at Hiroshima University Hospital and sixty-five patients with surgically resected invasive PHCC were enrolled, and the diagnostic yields of intraductal ultrasonography (IDUS), peroral cholangioscopy (POCS), and pathological examinations were determined. Results: In six of seven (86%) patients with isolated IgG4-SC, the stricture was in the perihilar bile duct. IDUS showed that symmetrical wall thickening (40% vs. 5%, p = 0.04), homogeneous internal echo (80% vs. 5%, p < 0.001), and smooth outer margins (80% vs. 6%, p < 0.001) were more frequent in isolated IgG4-SC than in PHCC. POCS showed a smooth mucosal surface more frequent in isolated IgG4-SC (75% vs. 7%, p = 0.006). Only one patient had two pathological findings characteristic of IgG4-SC. The sensitivity for diagnosing PHCC was 81% using two or more combined sampling methods. Conclusions: Pathological examinations have limitations in the differential diagnosis of isolated-IgG4-SC and PHCC, and a diagnostic strategy that combines multiple ERCP-related procedures, including IDUS and POCS, is recommended.

30 October 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SMSayaka Miyamoto
Sayaka Miyamoto
MSMasahiro Serikawa
Masahiro Serikawa
YIYasutaka Ishii
Yasutaka Ishii
YTYumiko Tatsukawa
Yumiko Tatsukawa
SNShinya Nakamura
Shinya Nakamura
SOShiro Oka
Shiro Oka
This study aimed to evaluate primary clinical outcomes in patients who underwent endoscopic papillectomy (EP) using the Endocut mode while examining the pathological characteristics of the margin of the resected specimen. To this end, 70 patients who underwent Endocut EP were included. Resection margins were classified according to pathological findings as “negative”, “positive”, or “uncertain (difficult pathological evaluation)”. The effect of pathological resection margins on residual tumor recurrence rates was evaluated. The median follow-up was 47 months (range, 22–84). Eleven patients (15.7%) were diagnosed with residual tumors, ten of whom were diagnosed within 6 months after EP. The resection margins were pathologically negative in 27 patients, positive in 15, and uncertain in 28; residual tumors occurred in 5 patients (33.3%) in the positive group, 5 (17.9%) in the uncertain group, and 1 (3.7%) in the negative group. The patient in the negative group had familial adenomatous polyposis (FAP). Female sex, FAP, and uncertain or positive resection margins were significantly more common in residual patients (p = 0.009, 0.044, and 0.041, respectively). Pathological resection margins can be used to infer the residual tumor incidence, leading to early post-treatment of residual tumors.

23 September 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
THTetsuro Hirano
Tetsuro Hirano
MSMasahiro Serikawa
Masahiro Serikawa
YIYasutaka Ishii
Yasutaka Ishii
SNShinya Nakamura
Shinya Nakamura
JIJuri Ikemoto
Juri Ikemoto
SOShiro Oka
Shiro Oka
Background/Objectives: There is limited evidence on imaging characteristics and pathological grading of small pancreatic neuroendocrine tumors (PNENs). This study aimed to compare imaging features and histopathological diagnoses of PNENs based on tumor size. Methods: Patients with PNEN who underwent pathological diagnosis at Hiroshima University Hospital were retrospectively reviewed. Detection rates, imaging findings, and diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) were analyzed according to tumor size. Results: Among 107 patients with PNEN, 42 had tumors ≤10 mm, and 65 had tumors >10 mm. The detection rate for lesions ≤10 mm was 92.3% according to EUS and 83.3% according to contrast-enhanced CT, showing the superior sensitivity of EUS. Typical imaging features—well-defined margins, homogeneous internal structure, and early enhancement—were significantly more frequent in tumors ≤10 mm (p < 0.001). There were no significant differences in imaging findings between G1 and G2 tumors ≤10 mm. The diagnostic sensitivity of EUS-FNA was 91.2% for tumors ≤10 mm and 86.3% for tumors >10 mm, with no significant difference. However, the concordance rate between EUS-FNA and surgical histology for tumor grading was significantly higher in the ≤10 mm group (87.5% vs. 56.3%, p = 0.012). Discussion: In small PNENs (≤10 mm), imaging features are often typical but do not reliably determine tumor grade. In our cohort, EUS-FNA showed high diagnostic accuracy and provided essential pathological information to guide management, including the choice between surveillance and surgery.

19 February 2026 in Cancers
Verified
Journal Article
Open access
PDF file
NINoriaki Iijima
Noriaki Iijima
YIYasutaka Ishii
Yasutaka Ishii
SNShinya Nakamura
Shinya Nakamura
JIJuri Ikemoto
Juri Ikemoto
MFMasaru Furukawa
Masaru Furukawa
SOShiro Oka
Shiro Oka
Background: Immune-mediated cholangitis (IMC) is a rare complication of immune checkpoint inhibitor (ICI) therapy, and its clinical characteristics and prognostic implications remain unclear. This study aimed to clarify the characteristics, risk factors, and outcomes of IMC compared with non-cholangitis cases of immune-mediated hepatotoxicity (IMH). Methods: In this single-center retrospective study, 1332 patients who received ICIs between 2014 and 2023 were analyzed. IMH was diagnosed based on liver enzyme elevation and exclusion of other liver diseases, while IMC was identified through characteristic imaging findings. Baseline factors, clinical presentations, treatment responses, and overall survival (OS) were evaluated. Multivariate analysis identified IMC risk and IMH prognostic factors. Results: Among the cohort, 81 (6.1%) patients had IMH, including 10 (0.8%) with IMC. Baseline eosinophil count > 270/μL (odds ratio [OR] 10.33, p = 0.004) and C-reactive protein (CRP) levels > 0.8 mg/dL (OR 6.260, p = 0.027) were independent predictors of IMC. IMC was associated with delayed onset, cholestatic liver injury, abdominal pain, and neutrophil-predominant inflammation. In prognostic analysis, IMC was not associated with OS. However, cholestatic liver injury (hazard ratio [HR] 2.318, p = 0.023) and neutrophil-to-lymphocyte ratio (NLR) ≥ 4.0 (HR 3.622, p = 0.001) were independent predictors of poor OS. Bile duct imaging abnormalities before or after onset were common in patients with treatment-resistant IMC. Conclusions: Baseline eosinophil count and CRP may help predict IMC. While IMC was not a prognostic factor, cholestatic injury and high NLR were associated with worse outcomes. IMC exhibits distinct clinical features, and radiologic findings may support earlier diagnosis and management.

28 September 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MFMasaru Furukawa
Masaru Furukawa
YIYasutaka Ishii
Yasutaka Ishii
MSMasahiro Serikawa
Masahiro Serikawa
TTTomofumi Tsuboi
Tomofumi Tsuboi
YTYumiko Tatsukawa
Yumiko Tatsukawa
SOShiro Oka
Shiro Oka
Objectives: We aimed to compare the utility of covered self-expanding metal stents (CSEMSs) with that of plastic stents (PSs) for biliary drainage during neoadjuvant chemotherapy in patients with borderline resectable pancreatic cancer. Methods: Forty patients with borderline resectable pancreatic cancer underwent biliary stenting during neoadjuvant chemotherapy at Hiroshima University Hospital. PSs and CSEMSs were placed in 19 and 21 patients, respectively. Two gemcitabine-based regimens for chemotherapy were used. Treatment outcomes and postoperative complications were compared between both groups. Results: The incidence of recurrent biliary obstruction was significantly lower in the CSEMS group (0% vs. 47.4%, p < 0.001), and the median time to recurrent biliary obstruction in the PS group was 47 days. There was no difference in the incidence of other complications such as non-occlusive cholangitis, pancreatitis, and cholecystitis between the two groups. Delays in the chemotherapy schedule due to stent-related complications were significantly frequent in the PS group (52.6% vs. 4.8%, p = 0.001). There was no significant difference in the incidence of postoperative complications between the two groups. Conclusions: CSEMSs may be the best choice for safely performing neoadjuvant chemotherapy for several months in patients with borderline resectable pancreatic cancer with bile duct stricture.